Jeffrey M. Steele

899 total citations
32 papers, 577 citations indexed

About

Jeffrey M. Steele is a scholar working on Pharmacology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Jeffrey M. Steele has authored 32 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 14 papers in Infectious Diseases and 12 papers in Clinical Biochemistry. Recurrent topics in Jeffrey M. Steele's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Jeffrey M. Steele is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Jeffrey M. Steele collaborates with scholars based in United States. Jeffrey M. Steele's co-authors include Wesley D. Kufel, Robert W. Seabury, Irving M. Klotz, Joseph A. Walder, Roxanne Y. Walder, Bryan T. Mogle, Christopher D. Miller, Stephen J. Thomas, Christopher Miller and William Darko and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Jeffrey M. Steele

29 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey M. Steele United States 13 271 175 125 120 111 32 577
R Maller Sweden 14 308 1.1× 161 0.9× 43 0.3× 160 1.3× 191 1.7× 28 635
Nieko Punt Netherlands 17 495 1.8× 237 1.4× 9 0.1× 77 0.6× 292 2.6× 44 939
Seok Hwee Koo Singapore 16 49 0.2× 68 0.4× 27 0.2× 39 0.3× 34 0.3× 49 702
William Knebel United States 11 233 0.9× 280 1.6× 8 0.1× 58 0.5× 60 0.5× 20 504
Valerie Berry United States 14 161 0.6× 85 0.5× 10 0.1× 23 0.2× 128 1.2× 20 708
Jodi M. Lestner United Kingdom 16 173 0.6× 567 3.2× 16 0.1× 22 0.2× 22 0.2× 18 818
Odin Naderer United States 12 236 0.9× 287 1.6× 6 0.0× 62 0.5× 49 0.4× 32 729
Pablo Vidal Spain 13 40 0.1× 78 0.4× 36 0.3× 103 0.9× 59 0.5× 55 622
Guojun Yuan United States 7 438 1.6× 51 0.3× 10 0.1× 74 0.6× 452 4.1× 18 925
Kim C. M. van der Elst Netherlands 11 123 0.5× 283 1.6× 7 0.1× 20 0.2× 14 0.1× 24 441

Countries citing papers authored by Jeffrey M. Steele

Since Specialization
Citations

This map shows the geographic impact of Jeffrey M. Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Steele more than expected).

Fields of papers citing papers by Jeffrey M. Steele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Steele. The network helps show where Jeffrey M. Steele may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Steele

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Steele. A scholar is included among the top collaborators of Jeffrey M. Steele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Steele. Jeffrey M. Steele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kufel, Wesley D., et al.. (2025). Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19. Annals of Pharmacotherapy. 59(12). 1086–1093. 2 indexed citations
2.
3.
Kufel, Wesley D., Robert W. Seabury, Jason C Gallagher, et al.. (2024). Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?. Open Forum Infectious Diseases. 11(11). ofae641–ofae641. 5 indexed citations
4.
Kufel, Wesley D., et al.. (2023). Impact of a Pharmacist-Conducted Preoperative Beta-Lactam Allergy Assessment on Perioperative Cefazolin Prescribing. Journal of Pharmacy Practice. 37(5). 1073–1081.
5.
Kufel, Wesley D., et al.. (2023). Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents. International Journal of Antimicrobial Agents. 62(1). 106843–106843. 7 indexed citations
6.
Kufel, Wesley D., et al.. (2023). Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia. Annals of Pharmacotherapy. 58(4). 360–365. 3 indexed citations
7.
Kufel, Wesley D., et al.. (2022). Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(1). 15–23. 7 indexed citations
8.
9.
Seabury, Robert W., et al.. (2022). Does a Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection?. Annals of Pharmacotherapy. 57(6). 669–676. 3 indexed citations
10.
Kufel, Wesley D., et al.. (2022). Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis. Journal of Antimicrobial Chemotherapy. 77(10). 2737–2741. 25 indexed citations
11.
Steele, Jeffrey M., et al.. (2021). Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections. Journal of Antimicrobial Chemotherapy. 76(6). 1379–1391. 47 indexed citations
12.
Kufel, Wesley D., Jeffrey M. Steele, Dongliang Wang, et al.. (2021). Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management. Diagnostic Microbiology and Infectious Disease. 101(4). 115535–115535. 5 indexed citations
13.
Kufel, Wesley D., et al.. (2021). Hospital Discharge: An Opportune Time for Antimicrobial Stewardship. Annals of Pharmacotherapy. 56(8). 869–877. 11 indexed citations
14.
Fazili, Tasaduq, Dongliang Wang, Jeffrey M. Steele, et al.. (2020). Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(4). 357–362. 15 indexed citations
15.
Seabury, Robert W., et al.. (2020). Cost comparison of AUC:MIC– versus trough-based vancomycin monitoring for MRSA bacteremia. Journal of the American Pharmacists Association. 60(5). 729–733. 2 indexed citations
16.
17.
Seabury, Robert W., William Darko, Christopher D. Miller, Jeffrey M. Steele, & Wesley D. Kufel. (2019). Publications for Pharmacy Residents Are Challenging but Not “Nearly Unattainable”. Hospital Pharmacy. 55(3). 153–153. 2 indexed citations
18.
Mogle, Bryan T., Jeffrey M. Steele, Robert W. Seabury, Utkarsh J. Dang, & Wesley D. Kufel. (2018). Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. International Journal of Antimicrobial Agents. 52(6). 805–810. 44 indexed citations
19.
Steele, Jeffrey M., et al.. (2017). Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. Journal of Clinical Pharmacy and Therapeutics. 43(1). 101–103. 30 indexed citations
20.
Mogle, Bryan T., et al.. (2017). Clinical review of delafloxacin: a novel anionic fluoroquinolone. Journal of Antimicrobial Chemotherapy. 73(6). 1439–1451. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Maller Breakdown of academic impact, for papers by Nieko Punt Breakdown of academic impact, for papers by Seok Hwee Koo Breakdown of academic impact, for papers by William Knebel Breakdown of academic impact, for papers by Valerie Berry Breakdown of academic impact, for papers by Jodi M. Lestner Breakdown of academic impact, for papers by Odin Naderer Breakdown of academic impact, for papers by Pablo Vidal Breakdown of academic impact, for papers by Guojun Yuan Breakdown of academic impact, for papers by Kim C. M. van der Elst
Rankless by CCL
2026